Key result
An elevated monocyte to high-density lipoprotein cholesterol ratio was independently associated with frequent premature ventricular complexes (OR 1.005) and predicted their presence with an AUC of 0.694.
Why the study?
Little is known about the relationship between the monocyte to high-density lipoprotein cholesterol ratio (MHR) and frequent premature ventricular complexes (PVCs).
Does the monocyte to high-density lipoprotein cholesterol ratio (MHR) predict frequent premature ventricular complexes (PVCs) and correlate with the ABC-VT risk score in hospitalized patients?
Cohort (n=270)
Yes
Does the monocyte to high-density lipoprotein cholesterol ratio (MHR) predict frequent premature ventricular complexes (PVCs) and correlate with the ABC-VT risk score in hospitalized patients?
Answers are grounded in this paper and cite their sources.
BACKGROUND: Little is known about the link between the monocyte to high-density lipoprotein cholesterol ratio (MHR) and frequent premature ventricular complexes (PVCs). This investigation aimed to evaluate the link between the MHR and frequent PVCs in patients, as well as their outcomes, using the axis, burden, coupling interval-ventricular tachycardia (ABC-VT) risk score (ARS). METHODS: Two hundred patients with frequent PVCs and 70 controls were retrospectively enrolled, and their general data were gathered. The MHR and ARS were calculated. Then, patients developing frequent PVCs were classified into a medium-/high-risk subgroup and a low-risk subgroup according to ARS. The results were evaluated employing comparative statistical analyses, Spearman's correlation, logistic regression analyses, and receiver operating characteristic (ROC) curves. RESULTS: The MHR in the controls was obviously lower than that in the frequent PVC group. In addition, the MHR was the lowest in the control group and highest in the medium-/high-risk subgroup, with that of the low-risk subgroup falling in the middle. Spearman's correlation analyses showed that the MHR was positively correlated with the ARS (ρ = 0.307, P < 0.001). Ultimately, the MHR was found to be a risk factor for frequent PVCs in the multivariate analysis. In addition, an MHR cutoff point of 254.6 featured 67.50% sensitivity and 67.14% specificity for predicting frequent PVCs, and the area under the curve (AUC) reached 0.694 (95% confidence interval: 0.623-0.766) (P < 0.001). CONCLUSIONS: The MHR is positively and independently correlated with frequent PVCs and can be used as a practical, cost-saving and simple biomarker of inflammation owing to its value in predicting frequent PVCs. In addition, the MHR is crucial to risk stratification and prognosis, which may give it clinical value in the prevention and management of frequent PVCs.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2022) conducted a cohort in Frequent premature ventricular complexes (n=270). Monocyte to high-density lipoprotein cholesterol ratio (MHR) vs. Lower MHR was evaluated on Presence of frequent premature ventricular complexes (OR 1.005, 95% CI 1.003-1.008, p=<0.001). An elevated monocyte to high-density lipoprotein cholesterol ratio was independently associated with frequent premature ventricular complexes (OR 1.005) and predicted their presence with an AUC of 0.694.
Synapse has enriched 10 related papers. Consider them for comparative context: